Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) FCF Margin (2023 - 2025)

Mangoceuticals' FCF Margin history spans 3 years, with the latest figure at 1142.18% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 6892.0% to 1142.18% in Q4 2025 year-over-year; TTM through Dec 2025 was 1282.89%, a 49315.0% decrease, with the full-year FY2025 number at 1282.89%, down 49315.0% from a year prior.
  • FCF Margin hit 1142.18% in Q4 2025 for Mangoceuticals, up from 1473.38% in the prior quarter.
  • Over the last five years, FCF Margin for MGRX hit a ceiling of 462.94% in Q1 2024 and a floor of 2081.11% in Q1 2025.
  • Historically, FCF Margin has averaged 1106.1% across 3 years, with a median of 1019.96% in 2024.
  • Biggest five-year swings in FCF Margin: surged 133589bps in 2024 and later crashed -161817bps in 2025.
  • Tracing MGRX's FCF Margin over 3 years: stood at 694.73% in 2023, then tumbled by -54bps to 1073.26% in 2024, then dropped by -6bps to 1142.18% in 2025.
  • Business Quant data shows FCF Margin for MGRX at 1142.18% in Q4 2025, 1473.38% in Q3 2025, and 747.4% in Q2 2025.